Interleukin-33, the circulating sST2 ligand, was demonstrated in a previous study to potentially contribute to vascular remodeling of the pulmonary endothelium in idiopathic pulmonary arterial hypertension (iPAH) [9]. The gene discussed is IL33; the disease is idiopathic pulmonary arterial hypertension.